Isabelle Belin Chauvin
About Isabelle Belin Chauvin
Isabelle Belin Chauvin is the Associate Director Market Access Immuno-Oncology at Bristol-Myers Squibb, with extensive experience in market access and pricing management across various pharmaceutical companies and therapeutic areas.
Current Role at Bristol-Myers Squibb
Isabelle Belin Chauvin currently holds the position of Associate Director Market Access Immuno-Oncology at Bristol-Myers Squibb. She is based in Rueil-Malmaison and has been with the company since 2009. Her role involves strategic oversight in market access for immuno-oncology, leveraging over a decade of experience at the firm.
Previous Roles at Bristol-Myers Squibb
Before her current role, Isabelle worked as a Pricing Manager at Bristol-Myers Squibb from 2006 to 2008. During this two-year period, she was responsible for pricing strategies and market access initiatives, laying the foundation for her later specialization in immuno-oncology.
Professional Experience in Market Access and Pricing
Isabelle has held numerous roles in market access and pricing across several prominent pharmaceutical companies. She has worked as a Pricing Manager at Wyeth Pharmaceuticals from 2004 to 2006 and at Lundbeck from 2002 to 2003. Additionally, she has experience working in pricing for Novartis (2002) and market access roles at Roche, GSK, and Merck Serono, reflecting her extensive experience in various therapeutic areas including hepatitis C, cardiology, diabetes, oncology, and pain.
Educational Background
Isabelle Belin Chauvin has a strong academic background in health economics and medical law. She achieved a DESS in Economie de la Santé from Université Paris Dauphine in 1998 and another DESS in Droit Médical from Universités Tours-Poitiers in 1997. She also holds a Maîtrise in Droit des Affaires from Université Paris X Nanterre, earned in 1996.
Extensive Experience Across France
Throughout her career, Isabelle has worked in various locations across France, including Rueil-Malmaison, Paris, Neuilly-sur-Seine, Marly-le-Roi, and Boulogne-Billancourt. This diverse geographical experience has contributed to her nuanced understanding of regional market dynamics and regulatory environments.